Malignant Phyllodes Tumor of the Right Breast with Sacral Bone Metastasis- A Clinical Case from our Practice with A Literature Review

Authors

  • Lena Marinova Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria Author
  • Nikolay Kahchiev Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria Author
  • Vaska Vasileva Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria Author
  • Katia Sergieva Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria Author

DOI:

https://doi.org/10.47363/JJCMR/2024(4)162

Keywords:

Phyllodes Breast Tumor, Malignant Phyllodes Tumor, Immunohistochemistry, Bone Metastasis, Palliative Intensity Modulated Radiotherapy

Abstract

Phyllodes breast neoplasms are rarely diagnosed biphasic tumors that are benign, borderline, or malignant. We present a rare malignant phyllodes tumor in a 62-year-old woman with bone metastasis in the sacrum, presented 4 months after radical breast tumor surgery. Because of a severe pain syndrome, we performed intensity modulated radiotherapy with a high single dose of 8 Gy in two fractions, once a week.


In this article we emphasize the difficult histopathological diagnosis, as well as the differential diagnosis, requiring immunohistochemistry of the two tumor components / epithelial and stromal/, as well as the clinical and pathological characteristics determining the malignant nature of the disease. In the presence of a soft tissue component of the bone metastasis, a biopsy with immunohistochemistry is required to prove the histopathological diagnosis of the distant metastasis.


Distant metastases require complex treatment, including chemotherapy and palliative radiation therapy.

Author Biographies

  • Lena Marinova, Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

    Lena Marinova, Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria.  

  • Nikolay Kahchiev, Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

    Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria 

  • Vaska Vasileva, Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

    Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria 

  • Katia Sergieva, Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria

    Medical Oncology Clinic, Department of Radiation Oncology and Metabolic Brachytherapy, UMHAT “Queen Joanna” Sofia, Bulgaria 

Downloads

Published

2025-12-05